KEGG   DISEASE: Ain-Naz type of dysostosis multiplex
Entry
H02729                      Disease                                
Name
Ain-Naz type of dysostosis multiplex
Description
Ain-Naz type of dysostosis multiplex (DMAN) is a severe inherited skeletal dysplasia which resembles GlcNAc-1-phosphotransferase (GNPT) deficiency [DS:H00143]. It has been reported that mutations in LYSET/TMEM251 cause DMAN. Recently, LYSET has been discovered as a key regulator of the M6P pathway. LYSET is a Golgi-localized transmembrane protein important for the retention of the GNPT complex in the Golgi apparatus. GNPT is the enzyme that catalyzes the transfer of M6P.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C56  Lysosomal diseases
     H02729  Ain-Naz type of dysostosis multiplex
Gene
LYSET [HSA:26175] [KO:K26747]
Other DBs
ICD-11: 5C56.3Y
OMIM: 619345
Reference
  Authors
Ain NU, Muhammad N, Dianatpour M, Baroncelli M, Iqbal M, Fard MAF, Bukhari I, Ahmed S, Hajipour M, Tabatabaie Z, Foroutan H, Nilsson O, Faghihi MA, Makitie O, Naz S
  Title
Biallelic TMEM251 variants in patients with severe skeletal dysplasia and extreme short stature.
  Journal
Hum Mutat 42:89-101 (2021)
DOI:10.1002/humu.24139
Reference
  Authors
Qiao W, Richards CM, Jabs S
  Title
LYSET/TMEM251- a novel key component of the mannose 6-phosphate pathway.
  Journal
Autophagy 19:2143-2145 (2023)
DOI:10.1080/15548627.2023.2167376
Reference
  Authors
Zhang B, Yang X, Li M
  Title
LYSET/TMEM251/GCAF is critical for autophagy and lysosomal function by regulating the mannose-6-phosphate (M6P) pathway.
  Journal
Autophagy 19:1596-1598 (2023)
DOI:10.1080/15548627.2023.2167375
LinkDB

» Japanese version

DBGET integrated database retrieval system